FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Olmesartan Medoxomil Tablets
Status: Resolved
»Duration of Shortage: 03/12/2019 - 03/05/2020
»Therapeutic Categories: Cardiovascular

Expand all

Accord Healthcare Inc. (Revised 03/05/2020)

Company Contact Information:
866-941-7875

Presentation
  • 5mg, 30T (NDC 1672-9320-10)
  • 5mg, 90T (NDC 1672-9320-15)
  • 20mg, 30T (NDC 1672-9321-10)
  • 20mg, 90T (NDC 1672-9321-15)
  • 40mg, 30T (NDC 1672-9322-10)
  • 40mg, 90T (NDC 1672-9322-15)
Note:
  • N/A

Alembic Pharmaceuticals (Revised 03/05/2020)

Company Contact Information:
908-393-9604

Presentation
  • 5mg, Bottle of 30 counts (NDC 62332-131-30)
  • 20mg, Bottle of 30 counts (NDC 62332-132-30)
  • 20mg, Bottle of 90 counts (NDC 62332-132-90)
  • 40mg, Bottle of 30 counts (NDC 62332-133-30)
  • 40mg, Bottle of 90 counts (NDC 62332-133-90)
Note:
  • N/A

Alkem Laboratories (Revised 03/05/2020)

Company Contact Information:
201-476-9445

Presentation
  • Olmesartan Medoxomil 20mg 30 Tabs (NDC 67877-0446-30)
  • Olmesartan Medoxomil 20mg 90 Tabs (NDC 67877-0446-90)
  • Olmesartan Medoxomil 40mg 30 Tabs (NDC 67877-0447-30)
  • Olmesartan Medoxomil 40mg 90 Tabs (NDC 67877-0447-90)
  • Olmesartan Medoxomil 5mg 30 Tabs (NDC 67877-0445-30)
Note:
  • N/A

Aurobindo Pharma (Revised 03/05/2020)

Company Contact Information:
866-850-2876

Presentation
  • 5mg, 30 ct. (NDC 65852-0741-30)
  • 20mg, 30 ct. (NDC 65862-0742-30)
  • 20mg, 90 ct. (NDC 65862-0742-90)
  • 40mg, 30 ct. (NDC 65862-0743-30)
  • 40mg., 90 ct. (NDC 65862-0743-90)
Note:
  • N/A

Daiichi Sankyo, Inc. (Revised 03/05/2020)

Company Contact Information:
908-992-7001

Presentation
  • 5mg, 30 Unit (NDC 65597-101-30)
  • 20mg, 30 Unit (NDC 65597-103-30)
  • 20mg, 90 Unit (NDC 65597-103-90)
  • 40mg, 30 Unit (NDC 65597-104-30)
  • 40mg, 90 Unit (NDC 65597-104-90)
Note:
  • N/A

Glenmark Pharmaceuticals (Revised 03/05/2020)

Company Contact Information:
888-721-7115

Presentation
  • 5mg (NDC 68462-0436-30)
  • 20mg (NDC 68462-0437-30)
  • 20mg (NDC 68462-0437-90)
  • 40mg (NDC 68462-0438-30)
  • 40mg (NDC 68462-0438-90)
Note:
  • N/A

Mylan Pharmaceuticals Inc. (Revised 03/05/2020)

Company Contact Information:
800-796-9526

Presentation
  • Olmesartan Medoxomil 5mg T 30s (NDC 0378-7012-93)
  • Olmesartan Medoxomil 20mg T 30s (NDC 0378-7112-93)
  • Olmesartan Medoxomil 20mg T 90s (NDC 0378-7112-77)
  • Olmesartan Medoxomil 40mg T 30s (NDC 0378-7124-93)
  • Olmesartan Medoxomil 40mg T 90s (NDC 0378-7124-77)
Note:
  • N/A

Torrent Pharma Inc. (Revised 03/05/2020)

Company Contact Information:
888-544-2299 option 4

Presentation
  • 5mg tablet (NDC 13668-248-30)
  • 20mg tablet (NDC 13668-249-30)
  • 20mg tablet (NDC 13668-249-90)
  • 40mg tablet (NDC 13668-250-30)
  • 40mg tablet (NDC 13668-250-90)
Note:
  • N/A

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English